[go: up one dir, main page]

ATE288257T1 - Trinkbare pharmazeutische suspension von ibuprofen - Google Patents

Trinkbare pharmazeutische suspension von ibuprofen

Info

Publication number
ATE288257T1
ATE288257T1 AT00917139T AT00917139T ATE288257T1 AT E288257 T1 ATE288257 T1 AT E288257T1 AT 00917139 T AT00917139 T AT 00917139T AT 00917139 T AT00917139 T AT 00917139T AT E288257 T1 ATE288257 T1 AT E288257T1
Authority
AT
Austria
Prior art keywords
ibuprofen
pharmaceutical suspension
drinkable
drinkable pharmaceutical
weight
Prior art date
Application number
AT00917139T
Other languages
English (en)
Inventor
Christophe Lebon
Emmanuel Guerin
Pascal Suplie
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9904251A external-priority patent/FR2791888B1/fr
Priority claimed from FR0004359A external-priority patent/FR2791889B1/fr
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of ATE288257T1 publication Critical patent/ATE288257T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT00917139T 1999-04-06 2000-04-06 Trinkbare pharmazeutische suspension von ibuprofen ATE288257T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (fr) 1999-04-06 1999-04-06 Suspension pharmaceutique buvable
FR0004359A FR2791889B1 (fr) 2000-04-05 2000-04-05 Suspension pharmaceutique buvable d'ibuprofene
PCT/FR2000/000869 WO2000059467A1 (fr) 1999-04-06 2000-04-06 Suspension pharmaceutique buvable d'ibuprofene

Publications (1)

Publication Number Publication Date
ATE288257T1 true ATE288257T1 (de) 2005-02-15

Family

ID=26212324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00917139T ATE288257T1 (de) 1999-04-06 2000-04-06 Trinkbare pharmazeutische suspension von ibuprofen

Country Status (10)

Country Link
US (1) US6794411B1 (de)
EP (1) EP1165042B1 (de)
CN (1) CN1190185C (de)
AT (1) ATE288257T1 (de)
AU (1) AU771516B2 (de)
BR (1) BR0009557A (de)
DE (1) DE60017881T2 (de)
ES (1) ES2234581T3 (de)
PT (1) PT1165042E (de)
WO (1) WO2000059467A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039687A1 (en) * 2001-08-01 2003-02-27 Michael Corbo Taste masking composition
CN101862292A (zh) * 2002-06-17 2010-10-20 塔罗制药美国公司 布洛芬混悬剂
ES2373229T3 (es) * 2003-02-06 2012-02-01 Gebro Pharma Gmbh Preparaciones farmacéuticas y procedimiento para su producción.
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
DE102007052071A1 (de) * 2007-10-30 2009-05-07 Stada Arzneimittel Ag Stabilisiertes Atorvastatin
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
CN102204882B (zh) * 2011-03-22 2013-07-24 韩彬 布洛芬的药物组合物
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
DE3900811A1 (de) 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
IE902829A1 (en) 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
JP2879905B2 (ja) 1989-08-28 1999-04-05 武田薬品工業株式会社 イブプロフェン含有経口投与用組成物
ES2071986T3 (es) 1990-04-11 1995-07-01 Upjohn Co Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado.
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
JP2814138B2 (ja) 1990-07-23 1998-10-22 エスエス製薬株式会社 懸濁シロップ剤
US5110606A (en) 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery
IL104093A (en) 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
AU670567B2 (en) 1992-03-05 1996-07-25 American Home Products Corporation Pharmaceutical coated cores
WO1994005260A1 (en) 1992-09-03 1994-03-17 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
US5635200A (en) 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
GB9224855D0 (en) 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
AU6774694A (en) 1993-04-26 1994-11-21 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5925376C1 (en) * 1994-01-10 2001-03-20 Madalene C Y Heng Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
EP0717992A3 (de) 1994-12-21 1998-03-25 McNEIL-PPC, INC. Formulierungen von wässrige Suspensionen für pharmazeutische Verwendung
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5563177A (en) 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
JPH11504940A (ja) 1995-05-09 1999-05-11 ザ、プロクター、エンド、ギャンブル、カンパニー 胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物
GB2318511A (en) 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
JPH10182449A (ja) 1996-12-25 1998-07-07 Kobayashi Seiyaku Kogyo Kk 易嚥下性イブプロフェン含有製剤
FR2771292B1 (fr) 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
DE60017881D1 (de) 2005-03-10
BR0009557A (pt) 2002-05-28
DE60017881T2 (de) 2006-04-13
CN1190185C (zh) 2005-02-23
CN1352548A (zh) 2002-06-05
EP1165042B1 (de) 2005-02-02
AU771516B2 (en) 2004-03-25
PT1165042E (pt) 2005-06-30
AU3825100A (en) 2000-10-23
WO2000059467A1 (fr) 2000-10-12
US6794411B1 (en) 2004-09-21
EP1165042A1 (de) 2002-01-02
ES2234581T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
MY136406A (en) High drug load tablet
FI970825L (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
ATE217523T1 (de) Loteprednoletabonat-suspension
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DK0749317T3 (da) Terapeutiske anvendelser af dimerprodukter af baktericidt/permeabilitetsforøgende protein
BR0209020A (pt) Composição farmacêutica de polialilamina
GB9920281D0 (en) Novel compositions of biologically active agents and their use
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
ATE288257T1 (de) Trinkbare pharmazeutische suspension von ibuprofen
WO1999006388A8 (en) Pharmaceutical compounds isolated from aristolochia taliscana
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
DE60103619D1 (de) Pharmazeutische zubereitungen enthaltend alginate
EA199900352A1 (ru) Композиции жидкого алендроната
DE60217903D1 (de) Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
MXPA02012015A (es) Ligandos de receptores para integrinas.
FR2821080B1 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
TR199900013T2 (xx) Yeni bile�ikler.
EA199800573A1 (ru) Таблетки с высоким содержанием фамцикловира
MX9603343A (es) Antagonistas del receptor endotelial, procedimiento para preparar dichos compuestos y preparaciones farmaceuticas que los contienen.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165042

Country of ref document: EP